Carregant...
Neoadjuvant chemoradiation followed by transanal local excision for T2 rectal cancer confers equivalent survival benefit as traditional transabdominal resection
BACKGROUND: Despite clinical guidelines classifying T2 rectal cancer as a contraindication for transanal local excision due to unacceptably high rates of local recurrence, it is a practice that persists clinically. Recent clinical trials have suggested that transanal local excision in addition to ne...
Guardat en:
| Publicat a: | Surgery |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6581580/ https://ncbi.nlm.nih.gov/pubmed/30904173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.surg.2019.02.005 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|